Corrigendum to “GDNF-expressing macrophages restore motor functions at a severe late-stage and produce long-term neuroprotective effects at an early-stage of Parkinson's disease in transgenic Parkin Q311X(A) mice”, [J Control Release, 315 (2019) 139–149] (Journal of Controlled Release (2019) 315 (139–149), (S0168365919305905), (10.1016/j.jconrel.2019.10.027))

Yuling Zhao, Matthew J. Haney, Yeon S. Jin, Olga Uvarov, Natasha Vinod, Yueh Z. Lee, Benjamin Langworthy, Jason P. Fine, Myosotys Rodriguez, Nazira El-Hage, Alexander V. Kabanov, Elena V. Batrakova

Research output: Contribution to journalComment/debatepeer-review

Abstract

The authors regret that in the initially published version of this article an error occurred in the Fig. 2 panels A and B showing representative whole-body dorsal IVIS images, and panels D and E showing main organs IVIS images. The respective panels for Parkinson's Disease (PD) mice and healthy wild type (WT) controls were accidentally switched and mislabeled. We present the Fig. 1 that is the correct version of Fig. 2 of the original manuscript. We also used correct dorsal images for the representative PD mouse for 4 h- and 24 h-post injection. Accordingly, the respective panels whole-body ventral IVIS images for PD mice and WT controls were also accidentally switched and mislabeled on Supplementary Fig. S5. We present the Fig. 2 here that is correct version of Supplementary Fig. S5. The corrections in the figures do not impact the conclusions of the study. [Figure presented] Fig. 1 This figure shows the corrected version of Fig. 2 of the original Article. [Figure presented] Fig. 2 This figure shows the corrected version of Supplementary Fig. S5 of the original Article.

Original languageEnglish (US)
Pages (from-to)813-814
Number of pages2
JournalJournal of Controlled Release
Volume343
DOIs
StatePublished - Mar 2022
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2022

Fingerprint

Dive into the research topics of 'Corrigendum to “GDNF-expressing macrophages restore motor functions at a severe late-stage and produce long-term neuroprotective effects at an early-stage of Parkinson's disease in transgenic Parkin Q311X(A) mice”, [J Control Release, 315 (2019) 139–149] (Journal of Controlled Release (2019) 315 (139–149), (S0168365919305905), (10.1016/j.jconrel.2019.10.027))'. Together they form a unique fingerprint.

Cite this